Mucosal immunity and vaccine development - Nature
Mucosal immunity and vaccine development Nature
Vaccines & Immunology News
COVID-19 mRNA vaccines: a prospective outlook from technological innovation to clinical practice - Frontiers
COVID-19 mRNA vaccines: a prospective outlook from technological innovation to clinical practice Frontiers
BSI response to reports on changes to childhood vaccination recommendations in the US - British Society for Immunology
BSI response to reports on changes to childhood vaccination recommendations in the US British Society for Immunology
Rapid boosting increases germinal center responses to sequential vaccines - Nature
Rapid boosting increases germinal center responses to sequential vaccines Nature
Vaccine symposium airs multiple ideas for accelerating preventive immunology - Stanford Medicine
Vaccine symposium airs multiple ideas for accelerating preventive immunology Stanford Medicine
Age-dependent immune landscapes affect influenza vaccine effectiveness and guide precision strategies - Frontiers
Age-dependent immune landscapes affect influenza vaccine effectiveness and guide precision strategies Frontiers
How Pa.'s falling school vaccination rates and enforcement failures put thousands of children at risk - Pittsburgh Post-Gazette
How Pa.'s falling school vaccination rates and enforcement failures put thousands of children at risk Pittsburgh Post-Gazette
Vaccines: protecting more than you think - British Society for Immunology
Vaccines: protecting more than you think British Society for Immunology
Immunogenicity and protective potential of a mucosal protein-only vaccine candidate for tuberculosis - Frontiers
Immunogenicity and protective potential of a mucosal protein-only vaccine candidate for tuberculosis Frontiers
T cell immunity in vaccination and disease - Nature
T cell immunity in vaccination and disease Nature
mRNA: the vaccine revolution - British Society for Immunology
mRNA: the vaccine revolution British Society for Immunology
Programming the immunological properties of mRNA vaccines for cancer - Nature
Programming the immunological properties of mRNA vaccines for cancer Nature
GenIV vaccines: bridging innovation to equity in neglected tropical diseases - Frontiers
GenIV vaccines: bridging innovation to equity in neglected tropical diseases Frontiers
mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression - Nature
mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression Nature
Possible role of pre-vaccination T-lymphocyte subpopulations in the antibody response to COVID-19 vaccines in children undergoing chemotherapy - Frontiers
Possible role of pre-vaccination T-lymphocyte subpopulations in the antibody response to COVID-19 vaccines in children undergoing chemotherapy Frontiers
Editorial: Dissecting malaria protective immunity: acquired by natural infection and/or vaccination - Frontiers
Editorial: Dissecting malaria protective immunity: acquired by natural infection and/or vaccination Frontiers
Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms | npj Vaccines - Nature
Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms | npj Vaccines Nature
RSV vaccine development: advances and fusion protein-focused strategies - Frontiers
RSV vaccine development: advances and fusion protein-focused strategies Frontiers
Epitope-spanning antigenic variation reprograms immunodominance and broadens immunity in sequential influenza vaccination - Nature
Epitope-spanning antigenic variation reprograms immunodominance and broadens immunity in sequential influenza vaccination Nature
A guide to vaccinology: from basic principles to new developments - Nature
A guide to vaccinology: from basic principles to new developments Nature
Cancer vaccines as enablers of immunotherapy - Nature
Cancer vaccines as enablers of immunotherapy Nature
Covid-19 Vaccines — Immunity, Variants, Boosters - NEJM
Covid-19 Vaccines — Immunity, Variants, Boosters NEJM
Blood test can predict how long vaccine immunity will last, Stanford Medicine-led study shows - Stanford Medicine
Blood test can predict how long vaccine immunity will last, Stanford Medicine-led study shows Stanford Medicine
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses - Nature
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses Nature
Eliciting antitumor immunity via therapeutic cancer vaccines - Nature
Eliciting antitumor immunity via therapeutic cancer vaccines Nature
Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice - Nature
Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice Nature
COVID-19 vaccines: modes of immune activation and future challenges - Nature
COVID-19 vaccines: modes of immune activation and future challenges Nature
Precision Vaccine Development: Cues From Natural Immunity - Frontiers
Precision Vaccine Development: Cues From Natural Immunity Frontiers
Induction of Trained Immunity by Recombinant Vaccines - Frontiers
Induction of Trained Immunity by Recombinant Vaccines Frontiers
Editorial: Mucosal immunity after vaccination - Frontiers
Editorial: Mucosal immunity after vaccination Frontiers
Potential of mRNA-based vaccines for the control of tick-borne pathogens in one health perspective - Frontiers
Potential of mRNA-based vaccines for the control of tick-borne pathogens in one health perspective Frontiers
Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines | Mucosal Immunology - Nature
Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines | Mucosal Immunology Nature
Immunological considerations for COVID-19 vaccine strategies - Nature
Immunological considerations for COVID-19 vaccine strategies Nature
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants - Science | AAAS
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants Science | AAAS
Mucosal vaccines — fortifying the frontiers - Nature
Mucosal vaccines — fortifying the frontiers Nature
Current Challenges in Vaccinology - Frontiers
Current Challenges in Vaccinology Frontiers
Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects - Frontiers
Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects Frontiers
Q fever immunology: the quest for a safe and effective vaccine - Nature
Q fever immunology: the quest for a safe and effective vaccine Nature
Viral targets for vaccines against COVID-19 - Nature
Viral targets for vaccines against COVID-19 Nature
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination - Nature
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination Nature